NCT Number: NCT04323618
Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing SBRT Using Audiovisual Biofeedback
Investigation of respiratory-related tumour motion in liver cancer patients undergoing stereotactic body radiotherapy treatment (SBRT) using audiovisual (AV) biofeedback.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Liver cancer patients, either primary hepatocellular carcinoma or liver metastases, eligible for stereotactic radiotherapy.
- >18 years old
- Radio-opaque markers implanted (fiducials and/or surgical clips previously implanted in the liver)
- Able to give written informed consent and willingness to participate and comply with the study
Exclusion criteria
- Pregnant / lactating women
Treatment and study plan
Primary outcomes
-
Improvement in reproducibility of respiratory-related tumour motion (via fiducial maker surrogacy) for liver cancer patients treated with the AV biofeedback respiratory guidance system.
Time frame: 2 years
Sponsors and collaborators
Lead sponsor
University of Sydney
Other
Registry information
Official study title
Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing Stereotactic Body Radiotherapy Treatment (SBRT) Using Audiovisual (AV) Biofeedback
Acronym: LAVA
Important dates
- Study start
- 2014
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Mar 26, 2020
- Registry last updated
- Apr 4, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy
NCT05176860
Breast Cancer, Breast Diseases
Halifax, Nova Scotia, Canada
View Trial DetailsA Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer
NCT06863233
Bronchial Neoplasms, Carcinoma, Bronchogenic
Basking Ridge, New Jersey, United States
View Trial DetailsBELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
NCT01562028
Bronchial Neoplasms, Carcinoma, Bronchogenic
Caen, France
View Trial DetailsOvarian-Sparing Adaptive Radiotherapy in Young Adult Women
NCT06904365
Anal Cancer, Anus Diseases
St Louis, Missouri, United States
View Trial Details